New potential drug target for Alzheimer’s disease

Tau protein is implicated in many neurogenerative diseases, including Alzheimer’s. New findings point to a new potential drug target to slow the progress of the disease: the enzymes responsible for sulfation called heparan sulfate 3-O transferases.